1. Pilat, Jennifer M, Brown, Rachel E, Chen, Zhengyi, Short, Sarah P, Williams, Christopher S. 2023. SELENOP modifies sporadic colorectal carcinogenesis and WNT signaling activity through LRP5/6 interactions. In The Journal of clinical investigation, 133, . doi:10.1172/JCI165988. https://pubmed.ncbi.nlm.nih.gov/37166989/
2. Wang, Chengdi, Yu, Qiuxiao, Song, Tingting, Zhang, Li, Li, Weimin. 2022. The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing. In Signal transduction and targeted therapy, 7, 289. doi:10.1038/s41392-022-01130-8. https://pubmed.ncbi.nlm.nih.gov/36008393/
3. Christen, Matthias, Högler, Sandra, Kleiter, Miriam, Jagannathan, Vidhya, Leeb, Tosso. 2021. Deletion of the SELENOP gene leads to CNS atrophy with cerebellar ataxia in dogs. In PLoS genetics, 17, e1009716. doi:10.1371/journal.pgen.1009716. https://pubmed.ncbi.nlm.nih.gov/34339417/
4. Hackler, Julian, Demircan, Kamil, Chillon, Thilo Samson, Renko, Kostja, Schomburg, Lutz. 2022. High throughput drug screening identifies resveratrol as suppressor of hepatic SELENOP expression. In Redox biology, 59, 102592. doi:10.1016/j.redox.2022.102592. https://pubmed.ncbi.nlm.nih.gov/36586222/